Navigation Links
ClearTrial Unveils New Product Release at Partnerships in Clinical Trials Conference 2010
Date:4/12/2010

based on pre-defined distribution curves. These new features will enable customers to more accurately assign and distribute pass through costs resulting in more precise forecasting and budgeting.

Expanded Country-specific Industry Intelligence – ClearTrial v3.2 expands the embedded clinical intelligence of the software to more than 80 countries worldwide. Featuring country-specific awareness for labor rates as well as for tasks affecting study timelines – such as site activation and regulatory delays – ClearTrial v3.2 supports the increasingly global nature of studies. This expanded capability makes it easier to model "what-if" scenarios that include the emerging countries and regions experiencing rapid growth in clinical trials.

Extended Global Currency Support – ClearTrial v3.2 has extended its global currency support to allow entry of alternate currencies for any study assumption that requires a monetary value. Alternate currencies are automatically converted based on predefined exchange rate conversion rules and on-demand reports can be printed in any currency of choice. These new capabilities will improve study planning in multiple geographies and eliminate manual and error prone currency conversions.

Reporting and Visualization – ClearTrial v3.2 delivers a host of additional tabular and graphical reports to its already extensive library of planning, forecasting and budgeting reports and graphs. These new reports will dramatically improve visibility across the lifecycle of a study.

About ClearTrial®
ClearTrial is the leading provider of Clinical Trial Operations (CTO) software, linking clinical planning, forecasting, and tracking of operational and financial performance in a single, integrated system. ClearTrial’s award-winning software helps life sciences companies streamline their clinical operations from Plan to Payment™ without sacrificing quality of r
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ClearTrial to Demonstrate How a Top 20 Sponsor Achieved -1 Percent Cost Variance Across Their $130M Clinical Portfolio at Major Industry Conference
2. ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress
3. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
4. ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference
5. ClearTrial to Demonstrate Dramatic Gains in Clinical Outsourcing Efficiency Achieved by Biopharmaceutical Companies at European Outsourcing Event
6. ClearTrial Names Proven Enterprise Software and Life Sciences Sales Leader Craig Smith as Vice President of Sales
7. ClearTrial Launches Industry-first Software Platform for Integrating Clinical Trial Operations from Plan to Cash™, Driving Operational Efficiencies and Accelerating Clinical Development
8. ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference
9. ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials
10. ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
11. ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 Nuvilex, Inc. (OTCQB: NVLX) – According ... worldwide are living with diabetes, with  that number expected ... global market for diabetes treatments is approximately $500 billion.  ... died from pancreatic cancer.  Pancreatic cancer is the fourth ... the United States , and according ...
(Date:10/22/2014)... HONG KONG , Oct. 22, 2014 /PRNewswire/ ... announced today that rare disease expert John C. ... research. Dr. McKew brings more than two decades of ... the National Institutes of Health, Wyeth Research and Genetics ... will lead aTyr,s efforts to expand and translate its ...
(Date:10/20/2014)... YORK , Oct. 20, 2014 ... their experimental ZMapp™ antibody therapeutic to fight the ... how difficult and time-consuming the production of pharmaceuticals ... market research publisher said that while some may ... of this compound, those with industry knowledge are ...
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
... XIFIN Inc., the leading provider of revenue ... that XIFIN,s CEO and Executive Chairman, Lale ... College Conference in New Orleans on April ... executives, laboratory administrators and pathologists from many ...
... friendlyHOUSTON, April 14 US Oncology, Inc., supporting the nation,s ... Web site, usoncology.com . In order to ... usoncology.com is part of a new branding effort ... aspect of cancer care. , , For the ...
... field of medical microbiology, biodefense and pathogens to febit, ... and HEIDELBERG, Germany, April 14 febit ... Ph.D., for its Scientific Advisory Board. Dr. Keim ... Division at TGen (The Translational ...
Cached Biology Technology:XIFIN Inc. CEO to Speak at Executive War College Conference 2XIFIN Inc. CEO to Speak at Executive War College Conference 3US Oncology Launches New Web Site 2US Oncology Launches New Web Site 3US Oncology Launches New Web Site 4US Oncology Launches New Web Site 5US Oncology Launches New Web Site 6Paul Keim Appointed to febit's Scientific Advisory Board 2
(Date:10/25/2014)... 22, 2014 This report covers the specifics ... space in heavy pursuit of research due to its ... compared to other RNA components. miRNA,s non-coding nature and ... candidate for use as a biomarker for a variety ... and diagnostics for the advancement in therapeutic development. Furthermore ...
(Date:10/22/2014)... -- Leading identity analyst firm Acuity Market Intelligence forecasts that ... will have a chip-based National eID card, including near-complete ... Asia , with its vast population, is ... 60% of all National eID cards issued between 2014 ... National eID Industry Report: 2014 Edition" — ...
(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
Breaking Biology News(10 mins):MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics Overview, Cambridge Healthtech Advisors 2Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3
... In a paper being presented in two American ... joint Estonian-French team demonstrated "for the first time ... suggesting that mitochondria may mechanically regulate nuclear function." ... over 10 years, reported that it recently "found ...
... of biology's most fundamental questions ?why males produce sperm ... a breakthrough that could lead to improved infertility treatment, ... led by Dr Josephine Bowles and Professor Peter Koopman ... of Queensland, has discovered that derivatives of Vitamin A ...
... Virginia Tech in the United States have determined the ... production xanthurenic acid (XA) in Anopheles gambiae, the malaria ... sexual reproduction of the malaria parasite (Plasmodium falciparum) in ... could be an avenue for development of drugs and ...
Cached Biology News:First direct mechanical communication of mitochondria, cardiomyocyte nucleus shown 2First direct mechanical communication of mitochondria, cardiomyocyte nucleus shown 3One big biology question solved 2Oxidation defense in mosquitoes benefits malaria parasite 2
Mouse monoclonal [N7519] to NR0B2 ( Abpromise for all tested applications). Antigen: E.coli expressed recombinant full length protein (Human) NR0B2 Entrez Gene ID: 8431 Swiss Protein ID: ...
Rabbit polyclonal to BCA1 ( Abpromise for all tested applications). Antigen: Generated using E.coli expressed mouse BCA1. Entrez GeneID: 10563 SWISS Protein ID: O43927...
PKC Sampler Kit 10 mu g each...
Purified anti-SOCS3...
Biology Products: